{"id":"https://openalex.org/W2185976199","doi":null,"title":"The Application of Drug-Disease and Clinical Utility Models in the Design of AWARD-5: an Adaptive Seamless Phase 2/3 Study","display_name":"The Application of Drug-Disease and Clinical Utility Models in the Design of AWARD-5: an Adaptive Seamless Phase 2/3 Study","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W2185976199","mag":"2185976199"},"language":"en","primary_location":{"id":"mag:2185976199","doi":null,"is_oa":false,"landing_page_url":"http://www.page-meeting.org/pdf_assets/296-PAGE%20poster_Heathman.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078777880","display_name":"Michael A. Heathman","orcid":"https://orcid.org/0000-0001-8150-3782","observed_orcids":["https://orcid.org/0000-0001-8150-3782"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Heathman","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8150-3782","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010436601","display_name":"Zachary Skrivanek","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zachary Skrivanek","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044039185","display_name":"Brenda L. Gaydos","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brenda Gaydos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110243358","display_name":"Mary Jane Geiger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mary Jane Geiger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5047922681","display_name":"Jenny Y. Chien","orcid":"https://orcid.org/0000-0001-9303-5947","observed_orcids":["https://orcid.org/0000-0001-9303-5947"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jenny Y. Chien","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9303-5947","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.19901316,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.9315999746322632,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.9315999746322632,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.03200000151991844,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.010300000198185444,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8259999752044678},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.48399999737739563},{"id":"https://openalex.org/keywords/anti-obesity-drugs","display_name":"anti-obesity drugs","score":0.47999998927116394},{"id":"https://openalex.org/keywords/sibutramine","display_name":"sibutramine","score":0.8299999833106995},{"id":"https://openalex.org/keywords/rimonabant","display_name":"rimonabant","score":0.9430000185966492},{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":0.8080000281333923},{"id":"https://openalex.org/keywords/lorcaserin","display_name":"lorcaserin","score":0.8529999852180481},{"id":"https://openalex.org/keywords/trial-design","display_name":"trial design","score":0.4309999942779541}],"concepts":[{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6206766366958618},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.4801899194717407},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.46349549293518066},{"id":"https://openalex.org/C2982777018","wikidata":"https://www.wikidata.org/wiki/Q99268086","display_name":"Adaptive design","level":3,"score":0.46006572246551514},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.45503589510917664},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.427055299282074},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2528727650642395},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.22871705889701843},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18211862444877625},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.13772442936897278},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2185976199","doi":null,"is_oa":false,"landing_page_url":"http://www.page-meeting.org/pdf_assets/296-PAGE%20poster_Heathman.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7020911653","https://openalex.org/W4296899128","https://openalex.org/W6990423625","https://openalex.org/W4408870132","https://openalex.org/W3081336691","https://openalex.org/W2783612055","https://openalex.org/W7028753640","https://openalex.org/W4236862755","https://openalex.org/W2079554216","https://openalex.org/W2183282272"],"abstract_inverted_index":{"NoDM-Placebo":[0],"NoDM-Sibutramine":[1],"NoDM-Rimonabant":[2],"NoDM-Dexfenfluramine":[3],"NoDM-Lorcaserin":[4],"NoDM-Qsymia":[5],"T2DM-Placebo":[6],"T2DM-Sibutramine":[7],"T2DM-Exenatide":[8],"T2DM-Exen":[9],"LAR":[10],"T2DM-Lixisenatide":[11],"T2DM-Liraglutide":[12],"T2DM-Taspoglutide":[13],"T2DM-Albiglutide":[14],"T2DM-Lorcaserin":[15],"T2DM-Qsymia":[16]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}